Similar to 症例報告

Active placebo

Survival rate

Progression-free survival

AST/ALT ratio

0

Clinical research

GRADE approach

PDUFA date

Standard operating procedure

Threshold dose

Iclepertin

Drug development

Contract research organization

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Drug design

Direclidine

Xanomeline/trospium chloride

Placebo

Efficacy

Council for International Organizations of Medical Sciences

Evidence-based medicine

Expanded access

Experimental drug

Case series

New Drug Application

Postmarketing surveillance